Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study.
Pascale Fabbro-PeraySonia ZouaouiAmélie DarlixMichel FabbroJohan PalludValérie RigauHélène Mathieu-DaudeFaiza BessaoudFabienne BauchetAdeline RiondelElodie SorbetsMarie CharissouxAymeric AmelotEmmanuel MandonnetDominique Figarella-BrangerHugues DuffauBrigitte TretarreLuc TaillandierLuc BauchetPublished in: Journal of neuro-oncology (2018)
In non-progressive patients, prolonging the adjuvant temozolomide beyond 6 cycles may improve OS.
Keyphrases
- newly diagnosed
- prognostic factors
- early stage
- healthcare
- quality improvement
- end stage renal disease
- multiple sclerosis
- chronic kidney disease
- palliative care
- radiation therapy
- squamous cell carcinoma
- stem cells
- radiation induced
- locally advanced
- pain management
- mesenchymal stem cells
- peritoneal dialysis
- cell therapy
- rectal cancer